Gene-Gene Interactions Lead to Higher Risk for Development of Type 2 Diabetes in an Ashkenazi Jewish Population

• Rosalind J. Neuman ,

  * E-mail: rneuman@wustl.edu

  Affiliations Department of Psychiatry, Washington University School of Medicine, St. Louis, Missouri, United States of America, Department of Genetics, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Jon Wasson,

  Affiliation Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯
• Gil Atzmon,

  Affiliation Institute of Aging, Department of Medicine and Genetics, Albert Einstein College of Medicine, New York, New York, United States of America

  ⨯
• Julio Wainstein,

  Affiliation Diabetes Unit, The E. Wolfson Medical Center, Holon, Israel

  ⨯
• Yair Yerushalmi,

  Affiliation Endocrinology Unit, Clalit Health Organization, Tel-Aviv, Israel

  ⨯
• Joseph Cohen,

  Affiliation Diabetes Clinic, Macabbi Health Service, Tel Aviv, Israel

  ⨯
• Nir Barzilai,

  Affiliation Institute of Aging, Department of Medicine and Genetics, Albert Einstein College of Medicine, New York, New York, United States of America

  ⨯
• Ilana Blech,

  Affiliation Endocrinology and Metabolism Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• Benjamin Glaser,

  Affiliation Endocrinology and Metabolism Service, Hadassah-Hebrew University Medical Center, Jerusalem, Israel

  ⨯
• M. Alan Permutt

  Affiliation Department of Internal Medicine, Washington University School of Medicine, St. Louis, Missouri, United States of America

  ⨯